Dow Up0.05% Nasdaq Up0.24%

Synta Pharmaceuticals Corp. (SNTA)

3.03 Down 0.03(0.98%) 10:53AM EDT - Nasdaq Real Time Price
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.7
Mean Recommendation (last week):2.7

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:12.50
Median Target:9.00
High Target:27.00
Low Target:1.00
No. of Brokers:5

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Mar 12, 2014StifelDowngradeHoldSell
Aug 30, 2012Stifel NicolausInitiated Hold
Feb 28, 2011Canaccord GenuityUpgradeHoldBuy
Nov 9, 2010MLV CapitalInitiated Buy
Aug 26, 2010Morgan JosephInitiated Buy
Feb 19, 2010RBC Capital MktsInitiated Sector Perform
Feb 17, 2010Roth CapitalDowngradeBuyHold
Nov 5, 2009Roth CapitalUpgradeHoldBuy
Feb 27, 2009RBC Capital MktsDowngradeOutperformSector Perform
Feb 27, 2009Rodman & RenshawDowngradeMkt OutperformMkt Perform

More Upgrades & Downgrades for SNTA

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy1111

Data provided by Thomson/First Call

Currency in USD.